Skip to main content
Genetics and Molecular Biology logoLink to Genetics and Molecular Biology
. 2021 Mar 26;44(2):e20200399. doi: 10.1590/1678-4685-GMB-2020-0399

Alpha thalassemia and alpha-MRE haplotypes in Uruguayan patients with microcytosis and hypochromia without anemia

Ana María Soler 1, Bruna Facanali Piellusch 2, Lorena da Silveira 1, Gisele Audrei Pedroso 2, Pablo López 3, Enrique Savio 4, María de Fatima Sonati 2, Julio da Luz 1
PMCID: PMC7995682  PMID: 33769430

Abstract

Alpha thalassemia is the most common genetic disorder across the world, being the α-3.7 deletion the most frequent mutation. In order to analyze the spectrum and origin of alpha thalassemia mutations in Uruguay, we obtained a sample of 168 unrelated outpatients with normal hemoglobin levels with microcytosis and hypochromia from two cities: Montevideo and Salto. The presence of α-thalassemia mutations was investigated by gap-PCR, restriction endonucleases analysis and HBA2 and HBA1 genes sequencing, whereas the alpha-MRE haplotypes were investigated by sequencing. We found 55 individuals (32.7%) with α-thalassemia mutations, 51(30.4%) carrying the -α3.7 deletion, one with the -α4.2 deletion and three having the rare punctual mutation HBA2:c.-59C>T. Regarding alpha-MRE analysis, we observed a significant higher frequency of haplotype D, characteristic of African populations, in the sample with the -α3.7 deletion. These results show that α-thalassemia mutations are an important determinant of microcytosis and hypochromia in Uruguayan patients with microcytosis and hypochromia without anemia, mainly due to the -α3.7 deletion. The alpha-MRE haplotypes and the α-thalassemia mutations spectrum suggest a predominant, but not exclusive, African origin of these mutations in Uruguay.

Keywords: Alpha-thalassemia, alpha-MRE, microcytosis, hypochromia, Uruguay

Introduction

α-thalassemia is the most common genetic disorder across the world. It is mainly caused by deletions of one (-α) or both (--) HBA genes of the α-globin gene cluster, although small deletions or point mutations also contribute to the α-thalassemia mutations spectrum (Foglietta et al., 1996; Huisman et al., 1998; Steinberg et al., 2001).

The absence (a0-thalassemia) or reduction (a+-thalassemia) of α-globin synthesis produces an imbalance between a and b-globin chains. This imbalance results in a deficient synthesis of hemoglobin in erythroid cells, causing microcytosis (reduction of mean corpuscular volume, MCV) and hypochromia (reduction of mean corpuscular hemoglobin, MCH). Microcytosis and hypochromia with normal levels of HbA2 can also be due to iron deficiency or anemia of chronic disease (Weatherall and Clegg, 1981; Weiss and Goodnough, 2005).

Hematological alterations depend on the number of α-globin genes affected (Steinberg et al., 2001). They range from almost asymptomatic or mild microcytic anemia in individuals with one or two affected genes to life incompatibility in the case of the hydrops fetalis syndrome due to the loss of the four α-globin genes. The consequence of losing or carrying alterations in three genes is the presence of a hemolytic anemia with marked variation in phenotypic expression, characterized by the presence of H hemoglobin (b4) (Higgs et al., 1989).

α-thalassemia reaches high frequencies in regions where malaria is or has been endemic, as in African, Mediterranean basin and Southeast Asian populations (Weatherall and Clegg, 2001). Furthermore, α-thalassemia mutations have spread across the world by immigration and slave trade (Isola, 1975; Sans, 1994; Weatherall and Clegg, 2001).

The a+-thalassemia due to a deletion of 3.7Kb (-α3.7 deletion) is the most common cause of α-thalassemia, which affects both HBA1 and HBA2 genes, resulting in a single hybrid gene (HBA2-HBA1). Another frequent cause of a+-thalassemia is the deletion of 4.2Kb (-α4.2 deletion) which deletes the entire HBA2 gene (Higgs et al., 1989; Foglietta et al., 1996). African and some Asian populations present the highest frequencies of -α3.7 deletion, while the -α4.2 deletion is more frequent in Asian populations (Kattamis et al., 1996; Weatherall and Clegg, 2001). Both deletions are also observed in European and Mediterranean populations at variable frequencies. For example, in Sardinian and Cypriot populations the -α3.7 deletion frequency is 12.6% and 14.0% respectively, whereas in the Basque population it is practically inexistent (Steinberg et al., 2001; Weatherall and Clegg, 2001).

The loss of the two α-globin genes in cis results in a0-thalassaemias. In the Mediterranean region, the --MED and --20.5 deletions are the most frequent mutations, whereas in African populations they are almost absent (Kattamis et al., 1996; Steinberg et al., 2001; Weatherall and Clegg, 2001). On the other hand, the deletion of a pentanucleotide (TGAGG) located at the 5’ end of the HBA2 gene IVS-I (aHpHIa), a point mutation at the initiation codon (ATG-ACG) of the HBA2 gene (αNcoIα), as well as a point mutation (ATG-GTG) in the HBA1 gene (ααNcoI), are the most common non-deletional mutations of α-thalassemia in the Mediterranean region (Higgs et al., 1989; Foglietta et al., 1996; Kattamis et al., 1996; Steinberg et al., 2001).

For a pediatric Uruguayan population, da Luz et al. (2013) previously reported that the estimated incidence of α-thalassemia was 3.3% and that only the -α3.7 deletion was observed. The --20.5 mutation was observed only in one individual from an enriched sample with microcytosis and hypochromia without iron deficiency and normal levels of HbA2. Interestingly, the -α3.7 deletion was observed mainly in Afro-descendants, classification based on their ancestor’s origin (da Luz et al., 2013). Soler et al. (2016) reported for the first time in Latin America the -α5.2 deletion, a mutation observed in Greek and Italian populations (Pressley et al., 1980; Fortina et al., 1994).

Previous studies, have shown that the Uruguayan population is tri-hybrid, with a greater genetic contribution of European populations (~84%, mainly Spaniards and Italians) followed in smaller proportions by Native Americans (~10%) and sub-Saharan populations (~6%) (Sans, 1994; Hidalgo et al., 2005; Sans et al., 2006).

In order to contribute to knowledge of α-thalassemia mutations in the Uruguayan population, we analyzed 168 outpatients from Montevideo and Salto (117 and 51 respectively) who showed normal Hb levels and reduced levels of VCM and MCH. Additionally, to investigate the -α3.7 deletion origin, we sequenced the alpha-MRE region in individuals with and without this mutation.

Subjects and Methods

A total of 168 unrelated individuals among 1 and 84 years old were analyzed, 117 outpatients from Hospital de Clínicas - Universidad de la República (UdelaR), Montevideo and 51 from Hospital Regional Salto - Administración de Servicios de Salud del Estado (ASSE), recruited in 2015. The protocol and procedure employed in this research were in compliance with the Helsinki Declaration. Each subject and the children’s parents gave written informed consent to participate in the study.

All individuals present normal levels of Hb and diminished levels of VCM and MCH. In adults (≥15 years old) the Hb levels were ≥ 13 g/dL for men and ≥ 12 g/dL for women. For both sexes, the VCM and MCH levels were ≤ 80 fl and ≤ 27 pg respectively. For individuals between 12 and 15 years old, we considered Hb levels ≥ 12 and VCM and MCH levels ≤ 78 fl and ≤ 26 pg respectively. In children under 12 years old, the levels of Hb were greater than 11 g/dL. In the range between ≥ 5 and < 12 years old the VCM and MCH levels were ≤ 77 fl and ≤ 25 pg respectively, whereas for children under 5 years old VCM and MCH levels were ≤ 75 fl and ≤ 24 pg respectively. The Hb thresholds were according those established by World Health Organization (de Benoist et al., 2008) and the VCM and MCH levels according to Besses et al. (2007).

Genomic DNA was extracted from venous peripheral blood by the salting out method (Miller et al., 1988). All individuals were analyzed for the presence of deletional and non-deletional α-thalassemia mutations. The seven most common deletional α-thalassemia (-α3.7, -α4.2, --SEA, --FIL, --MED, -α20.5, and --THAI) were checked by multiplex gap polymerase chain reaction (gap-PCR) and agarose gel electrophoresis, according to conditions already described (Tan et al., 2001). The most common non-deletional alpha thalassemia mutations were analyzed by restriction fragment length polymorphism (RFLP) from products amplified by PCR (αHphα, αNcoIα and ααNcoI) (Hall et al., 1993). Additionally, HBA1 and HBA2 genes were sequenced to analyzes the presence of point mutations or small deletion (Pedroso et al., 2018; Dodé et al., 1990).

The α-MRE haplotypes were determined in 157 individuals: 78 individuals with the -α3.7 deletion and 79 without α-thalassemia mutations. A 310bp DNA fragment was amplified and sequenced according to conditions previously described (Harteveld et al., 2002). Haplotypes were constructed by assuming that the presence of two common haplotypes was more probable than the combination of one common and one rare haplotype or two rare haplotypes (Long et al., 1990; Castro de Guerra et al., 1997).

Statistical methods

The genotypic and allelic frequencies were estimated by gene counting. The Hardy-Weinberg equilibrium, the estimation of heterogeneity among the samples by the exact test of population differentiation, and the pairwise FST were evaluated using Arlequin software package v 3.5.2.2 (Excoffier and Lischer, 2010). FST distances between Uruguayan population and other populations were represented in two dimensions by multidimensional scaling (MDS) using the software SPSS 22.0 Data of other populations were obtained from Harteveld et al. (2002), Ribeiro et al. (2003) and from the 1000 Genomes Database.

Results

α-thalassemia mutations were found in 55 individuals (32.7%). The distribution and frequencies of α-thalassemia mutations are showed in Table 1. The -α3.7 deletion was the most frequent mutation observed, 49 individuals heterozygous -α3.7/αα and two homozygous -α3.7/-α3.7, whereas the -α4.2 deletion was observed in only one individual. Three individuals were heterozygous for the point mutation HBA2: c.-59C>T. The mutations distribution and frequencies do not differ significantly between the two cities (Montevideo and Salto) analyzed.

Table 1 -. Alpha thalassaemia mutations found in the Uruguayan microcytic and hypochromic sample.

Genotype Montevideo Salto Total
N (%) N (%) N (%)
αα/αα 77 (65.0) 36 (70.7) 113 (67.3)
3.7/αα 36 (30.8) 13 (25.5) 49 (29.2)
3.7/-α3.7 1 (0.9) 1 (1.9) 2 (1.2)
-a4.2/αα 1 (0.9) 1 (0.6)
HBA2:c.-59C>T 2 (1.7) 1 (1.9) 3 (1.7)
Total 117 51 168

The number of different α-MRE genotypes and α-MRE haplotypes are showed in Table 2 and Table S1. The distribution of α-MRE genotypes and α-MRE haplotypes were significantly different between individuals with and without the -α3.7 deletion (p<0.05).

Table 2 -. α-MRE genotypes in Uruguayan population with and without -a3.7 deletion.

Population a-MRE genotypes N p
AA (%) AB (%) AD (%) BB (%) BD (%) DD (%)
a3.7 deletion 23 (29.5) 31 (39.7) 10 (12.8) 5 (6.4) 8(10.3) 1 (1.3) 78 0.0053
aa/aa 32 (40.5) 33 (41.8) 1 (1.3) 11 (13.9) 2 (2.5) 79

Multidimensional scaling (MDS) showed the subsample without -α3.7 deletion grouped with other Latino-American populations whereas, the sample with the -α3.7 deletion was split from these in the second dimension and was found more related to African populations (Figure 1). The lower genetic distances from the subsample without the -α3.7 deletion were with Latin-American populations from Peru, Colombia, Puerto Rico and Mexico. However, the subsample with the -α3.7 deletion presented the lowest genetic distances with Africans and Afro-Latin-American populations (Table S2).

Figure 1 -. Multidimensional scaling (MDS) based on pairwise FST genetic distances calculated from alpha-MRE genotypes.

Figure 1 -

Stress: 0.01390; RSQ: 0.99913. -α3.7 CARRIERS & NON -α3.7 CARRIERS: Uruguayan populations. Green: African and African derived populations. YRI: Yoruba in Ibadan, Nigeria. ACB: African Caribbeans in Barbados. GWD: Gambian in Western Divisions in the Gambia. MSL: Mende in Sierra Leone. ESN: Esan in Nigeria. LWK: Luhya in Webuye, Kenya. AFR: Bantu-speaking Africans. PIG: Pygmies from the Central African Republic. Orange: Admixed Latin-American populations. PEL: Peruvians from Lima, Peru. PUR: Puerto Ricans from Puerto Rico. CLM: Colombians from Medellin, Colombia. MXL: Mexican Ancestry from Los Angeles USA. Blue: European populations. IBS: Iberian Population in Spain. TSI: Toscani in Italia. CEU: Northern and Western European Ancestry. FIN: Finnish in Finland. ITALIANS. DUTCH. GBR: British in England and Scotland. Black: Asian populations. IND: Indonesians from Java. CHN: Southern Chinese. INDIANS: Andra-Pradesh, India. (1000genomes; Harteveld et al., 2002; Ribeiro et al., 2003).

Discussion

Our results show that α-thalassemia mutations explain an important percentage (32.7%) of the microcytosis and hypochromia observed in the Uruguayan population without anemia. Furthermore, the -α3.7 deletion was the most frequent mutation. The only non-deletional α-thalassemia mutation observed (HBA2 c.-59C>T), affects the last nucleotide of TATA box. This mutation was reported only once in an individual from Australia. In vitro analysis shows a reduction of the transcriptional activity in 53.7% when compared with the normal allele (HBA2 wild type) (Qadah et al., 2014). In our study, this mutation was observed in three non-related individuals from two different regions of Uruguay. This data suggests a possible founder effect in the Uruguayan population.

The α-thalassemia observed frequency (32.7%) is similar to previously reported for Rio Grande do Sul, Brazil (31.7%) (Wagner et al., 2010). However, it is lower than the one reported for Campinas, Southeastern Brazil (49.9%) (Borges et al., 2001). The high frequency reported for Campinas could be explained by a greater African contribution in this population. Nevertheless, in the Campinas sub-sample self-reported as Caucasian, the α-thalassemia frequency was also higher (41.5%) than the observed for Rio Grande do Sul and Uruguay (Borges et al., 2001; Wagner et al., 2010; da Luz et al., 2013). We hypothesize that those differences may be due to African genetic ancestry not detected in this sub-sample. Several studies had showed that Latin-American self-reported as whites present variable levels of African and/or Native American genetic ancestry. For example, in a female population from Brasilia, the percentage of African ancestry in self-reported whites was 17.2% (Lins et al., 2011). Another explanation may be that the Campinas population self-reported as white presents a greater European contribution from populations with higher α-thalassemia frequencies, as South-Italians (Weatherall and Clegg, 2001).

The observed similarity between Rio Grande do Sul and Uruguay is according with the common historical origin from these populations as well as with genetic data showing a high similarity at DNA mitochondrial level (Marrero et al., 2007).

In relation to alpha-MRE haplotypes, the observed differences between the two Uruguayan subsamples (with and without 3.7 deletion) is due to a high frequency of haplotype D in α-thalassemia subsample (Table S1). Haplotype D is characteristic of African populations. It is practically absent in others populations and therefore, is a useful marker for African ancestry (Harteveld et al., 2002). Moreover, the haplotype B frequency for both Uruguayan subsamples was lower than the ones observed for European populations and similar to observed for other admixed Latin-American and Asian populations (Harteveld et al., 2002; Ribeiro et al., 2003). With exception of Pigmies populations, the MDS plot of FST genetic distances calculated from alpha-MRE haplotypes clearly discriminated among African, European and Asian populations. As expected, Native American populations were grouped with Asian populations. Furthermore, admixed Latin-American populations were placed at an intermediate position between Asian and European populations according to admixture degree. For example, Peruvian and Mexican populations, who have the greater Native American ancestry, were clustered with Asian populations, whereas Colombian and Puerto Rico populations were placed near European populations. Moreover, the Puerto Rico population, which has the greater African ancestry, was displaced towards the African cluster (Rishishwar et al., 2015; Norris et al., 2018). The position of the Uruguayan subsample without the -α3.7 deletion next to the Colombian population, agrees with previous reports about the genetic ancestry of these two populations. Similar to reported for a Colombian population from Medellin (Norris et al., 2018), the Uruguayan population shows a greater European genetic ancestry (76.2%-84%) followed in smaller proportions by Native Americans (10% - 14.7%) and African ancestry (6% - 9.1%) (Sans, 1994; Hidalgo et al., 2005; Sans et al., 2006; Bonilla et al., 2015). However, the Uruguayan α-thalassemia subsample is placed near African populations, suggesting a greater African ancestry in this subsample. This is in accordance with previous studies that had shown a greater African ancestry based on self-perception in individuals with the -α3.7 deletion (da Luz et al., 2013).

In summary, α-thalassemia mutations explain a significant proportion of microcytosis and hypochromia in the Uruguayan population. The alpha-MRE haplotypes and the α-thalassemia mutations spectrum observed suggest a predominant, but not exclusive, African origin of the -α3.7 deletion in Uruguay.

Acknowledgments

The authors would like to thank all patients who kindly participated in this study. We also thank Dra. Elza Miyuki Kimura for her technical support. This study received financial support from Coordenação de Aperfeiçoamento de Pessoal de Nivel Superior, Brazil and Universidad de la República, Uruguay (Programa CAPES-UdelaR, grant number no. 2014/00984-3), and Comisión Coordinadora del Interior, Uruguay (CCI-2015).

Supplementary material

The following online material is available for this article:

Table S1 - α-MRE haplotypes.
Table S2 - FST genetic distances.

References

  1. Besses C, Sans-Sabrafén J, Vives JL. Hematología Clínica. 5. Elsevier; Madrid: 2007. [Google Scholar]
  2. Bonilla C, Bertoni B, Hidalgo PC, Artagaveytia N, Ackermann E, Barreto I, Cancela P, Cappetta M, Egaña A, Figueiro G, et al. Breast cancer risk and genetic ancestry: a case-control study in Uruguay. BMC Women’s Health. 2015;15:11. doi: 10.1186/s12905-015-0171-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borges E, Wenning MRSC, Kimura EM, Gervasio SA, Costa FF, Sonati MF. High prevalence of alpha-thalassemia among individuals with microcytosis and hypochromia without anemia. Braz J Med Biol Res. 2001;34:759–762. doi: 10.1590/s0100-879x2001000600009. [DOI] [PubMed] [Google Scholar]
  4. Castro de Guerra DC, Hutz MH, Bortolini MC, Salzano FM. Beta-globin gene cluster haplotypes in an admixed Venezuelan population. Am J Hum Biol. 1997;9:323–327. doi: 10.1002/(SICI)1520-6300(1997)9:3<323::AID-AJHB5>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  5. da Luz J, Avila A, Icasuriaga S, Gongóra M, Castillo L, Serrón A, Kimura EM, Costa FF, Sans M, Sonati MDF. Frequency and spectrum of hemoglobinopathy mutations in a Uruguayan pediatric population. Genet Mol Biol. 2013;36:316–322. doi: 10.1590/S1415-47572013005000027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. de Benoist B, Cogswell M, Egli I, McLean E. Worldwide prevalence of anaemia 1993-2005. WHO Press; Genève: 2008. [DOI] [PubMed] [Google Scholar]
  7. Dodé C, Rochette JR, Krishnamoorthy R. Locus assignment of human α-globin mutations by selective amplification and direct sequencing. Br J Haematol. 1990;76:275–281. doi: 10.1111/j.1365-2141.1990.tb07884.x. [DOI] [PubMed] [Google Scholar]
  8. Excoffier L, Lischer HE. Arlequin suite ver 3.5: A new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour. 2010;10:564–567. doi: 10.1111/j.1755-0998.2010.02847.x. [DOI] [PubMed] [Google Scholar]
  9. Foglietta E, Deidda G, Graziani B, Modiano G, Bianco I. Detection of α-globin gene disorders by a simple PCR methodology. Haematologica. 1996;81:387–396. [PubMed] [Google Scholar]
  10. Fortina P, Parrella T, Sartore M, Gottardi E, Gabutti V, Delgrosso K, Mansfield E, Rappaport E, Schwartz E, Camaschella C. Interaction of a rare illegitimate recombination event and Poly A addition site mutation resulting in a severe form of alpha thalassemia. Blood. 1994;83:3356–3362. [PubMed] [Google Scholar]
  11. Hall GW, Thein SL, Newland AC, Chisholm M, Traeger‐Synodinos J, Kanavakis E, Kattamis E, Higgs DR. A base substitution (T→ C) in codon 29 of the α2‐globin gene causes α thalassaemia. Br J Haematol. 1993;85:546–552. doi: 10.1111/j.1365-2141.1993.tb03346.x. [DOI] [PubMed] [Google Scholar]
  12. Harteveld CL, Muglia M, Passarino G, Kielman MF, Bernini LF. Genetic polymorphism of the major regulatory element HS-40 upstream of the human alpha-globin gene cluster. Br J Haematol. 2002;119:848–854. doi: 10.1046/j.1365-2141.2002.03917.x. [DOI] [PubMed] [Google Scholar]
  13. Hidalgo PC, Bengochea M, Abilleira D, Cabrera A, Alvarez I. Genetic admixture estimate in the Uruguayan population based on the loci LDLR, GYPA, HBGG, GC and D7S8. Int J Hum Genet. 2005;5:217–222. [Google Scholar]
  14. Higgs DR, Vickers MA, Wilkie AO, Pretorius IM, Jarman AP, Weatherall DJ. A review of the molecular genetics of the human α-globin gene cluster. Blood. 1989;73:1081–1104. [PubMed] [Google Scholar]
  15. Huisman THJ, Carver MFH, Baysal E. A syllabus of thalassemia mutations. Sickle Cell Anaemia Foundation; Augusta: 1998. [Google Scholar]
  16. Isola E. La esclavitud en el Uruguay desde sus comienzos hasta su extinción (1743-1852). Comisión Nacional de Homenaje del Sesquicentenario de los hechos históricos de 1825. Talleres Gráficos Monteverde y Cia; Montevideo: 1975. [Google Scholar]
  17. Kattamis AC, Camaschella C, Sivera P, Surrey S, Fortina P. Human α‐thalassemia syndromes: detection of molecular defects. Am J Hematol. 1996;53:81–91. doi: 10.1002/(SICI)1096-8652(199610)53:2<81::AID-AJH5>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  18. Lins TC, Vieira RG, Abreu BS, Gentil P, Moreno-Lima R, Oliveira RJ, Pereira RW. Genetic heterogeneity of self-reported ancestry groups in an admixed Brazilian population. J Epidemiol. 2011;21:240–245. doi: 10.2188/jea.JE20100164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Long JC, Chakravarti A, Bohem CD, Antonarakis S, Kazazian HH. Phylogeny of human beta-globin haplotypes and its implications for recent human evolution. Am J Phys Anthropol. 1990;81:113–130. doi: 10.1002/ajpa.1330810112. [DOI] [PubMed] [Google Scholar]
  20. Marrero AR, Bravi C, Stuart S, Long JC, Pereira das Neves Leite F, Kommers T, Carvalho CMB, Pena SDJ, Ruiz-Linares A, Salzano FM, et al. Pre- and post-Columbian gene and cultural continuity: the case of the Gaucho from southern Brazil. Hum Hered. 2007;64:160–171. doi: 10.1159/000102989. [DOI] [PubMed] [Google Scholar]
  21. Miller SA, Dykes DD, Polesky HFRN. A simple salting out procedure for extracting DNA from human nucleated cell. Nucleic Acids Res. 1988;16:1215–1216. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Norris ET, Wang L, Conley AB, Rishishwar L, Mariño-Ramírez L, Valderrama-Aguirre A, Jordan IK. Genetic ancestry, admixture and health determinants in Latin America. BMC Genomics. 2018;19:75–87. doi: 10.1186/s12864-018-5195-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pedroso GA, Kimura EM, Santos MNN, Albuquerque DM, Malimpensa D, Jorge SE, Verissimo MPA, Costa FF, Sonati MF. Thalassemia major phenotype caused by HB Zürich-Albisrieden [α2 59(E8) Gly > Arg (HBA2:C.178G > C)] in a Brazilian child. Pediatr Blood Cancer. 2018;65:e27413. doi: 10.1002/pbc.27413. [DOI] [PubMed] [Google Scholar]
  24. Pressley L, Higgs DR, Aldridge B, Metaxatou-Mavromati A, Clegg JB, Weatherall DJ. Characterization of a new α thalassemia 1 defect due to a partial deletion of the α-globin gene complex. Nucleic Acids Res. 1980;8:4889–4898. doi: 10.1093/nar/8.21.4889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Qadah T, Finlayson J, Dennis M, Ghassemifar R. Molecular and cellular analysis of three novel alpha2-globin gene promoter mutations [HBA2:c.-59C>T], [HBA2:c.-81C>A] and [HBA2:c.-91G>A] reveal varying patterns of transcriptional and translational activities. Pathology. 2014;46:46–52. doi: 10.1097/PAT.0000000000000023. [DOI] [PubMed] [Google Scholar]
  26. Ribeiro DM, Figueredo MS, Costa FF, Sonati MF. Haplotypes of α-globin gene regulatory element in two Brazilian native populations. Am J Phys Anthropol. 2003;12:58–62. doi: 10.1002/ajpa.10193. [DOI] [PubMed] [Google Scholar]
  27. Rishishwar L, Conley AB, Wigington CH, Wang L, Valderrama-Aguirre A, Jordan IK. Ancestry, admixture and fitness in Colombian genomes. Sci Rep. 2015;5:12376. doi: 10.1038/srep12376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sans M. Estudio genético e histórico de la población del departamento de Tacuarembó, Uruguay. Universidad de la República; Montevideo: 1994. PhD. [Google Scholar]
  29. Sans M, Merriwether DA, Hidalgo PC, Bentancor N, Weimer TA, Franco MHLP, Alvarez I, Kemp BM, Salzano FM. Population structure and admixture in Cerro Largo, Uruguay, based on blood markers and mitochondrial DNA polymorphisms. Am J Hum Biol. 2006;18:513–524. doi: 10.1002/ajhb.20520. [DOI] [PubMed] [Google Scholar]
  30. Soler AM, Schelotto M, de Oliveira Mota N, Dorta Ferreira R, Sonati MDF, da Luz JA. The -(α)(5.2) deletion detected in a Uruguayan family: first case report in the Americas. Haemoglobin. 2016;40:289–292. doi: 10.1080/03630269.2016.1200072. [DOI] [PubMed] [Google Scholar]
  31. Steinberg MH, Forget BG, Higgs DR, Nagel RL. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. J R Soc Med. 2001;94:602–603. [Google Scholar]
  32. Tan ASC, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemia. Blood. 2001;98:250–251. doi: 10.1182/blood.v98.1.250. [DOI] [PubMed] [Google Scholar]
  33. The 1000 Genomes Project Consortium A global reference for human genetic variation. Nature. 2015;526:68–74. doi: 10.1038/nature15393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wagner SC, de Castro SM, Gonzalez TP, Santin AP, Filippon L, Zaleski CF, Azevedo LA, Amorin B, Callegari-Jacques SM, Hutz MH. Prevalence of common α-thalassemia determinants in south Brazil: Importance for the diagnosis of microcytic anemia. Genet Mol Biol. 2010;33:641–645. doi: 10.1590/S1415-47572010005000086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Weatherall DJ, Clegg JG. The thalassaemia syndromes. 3. Blackwell Scientific Publications; Oxford: 1981. [Google Scholar]
  36. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: An increasing global health problem. Bull World Health Organ. 2001;79:704–712. [PMC free article] [PubMed] [Google Scholar]
  37. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–1023. doi: 10.1056/NEJMra041809. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table S1 - α-MRE haplotypes.
Table S2 - FST genetic distances.

Articles from Genetics and Molecular Biology are provided here courtesy of Sociedade Brasileira de Genética

RESOURCES